Stay updated on 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial
Sign up to get notified when there's something new on the 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial page.

Latest updates to the 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe record presents a randomized Phase 3 study of intravenous magnesium sulfate dosing and nebulized budesonide for children with severe asthma exacerbations. It includes the study design, participation criteria, locations and contacts, and measures of treatment outcomes.SummaryDifference52%

- Check17 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA sitewide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer revision marker changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page for the study record shows a 403 Forbidden error instead of the study details, indicating access restrictions to the entry.SummaryDifference19%

Stay in the know with updates to 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial page.